Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Japanese chronic heart failure patients
NCT01115855Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 2010
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eplerenone in systolic heart failure (HFrEF), sponsored by Viatris. Started Jul 2010; status: completed.
02
Drugs
eplerenone
03
Conditions
systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT01115855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115855.